Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.
EUROPEAN JOURNAL OF HAEMATOLOGY(2004)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
EUROPEAN JOURNAL OF HAEMATOLOGY(2004)